Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41436-020-01013-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between periungual changes and myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies: A retrospective cohort study.
J Am Acad Dermatol
September 2024
Department of Dermatology, Osaka University Graduate School of Medicine, Suita, Japan.
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies).
Autoimmun Rev
September 2023
Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi 489-8642, Japan.
Coal-mining subsidence changed distribution of the microbiomes and their functional genes in a farmland.
J Basic Microbiol
May 2023
College of Forestry, Shandong Agricultural University, Tai'an, Shandong, China.
Land subsidence is a serious geological event, and can trigger severe environmental and ecological issues. In this study, the influences of coal-mining subsidence on distribution of farmland microbiomes and their functional genes were investigated by 16 S ribosomal RNA (rRNA) gene and metagenome sequencing. The results showed the existence of a core microbiome, which determined the community compositions across the subsidence farmland.
View Article and Find Full Text PDFA new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome.
Rheumatology (Oxford)
May 2023
Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Two novel anti-aminoacyl tRNA synthetase antibodies: Autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase.
Autoimmun Rev
December 2022
Department of Dermatology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan.
Article Synopsis
- Anti-aminoacyl-tRNA synthetase (anti-ARS) antibodies help identify a specific group of patients with inflammatory myopathies known as anti-synthetase syndrome, which also presents unique non-myopathic symptoms.
- Researchers screened over 300 Japanese patients, mainly with dermatomyositis (DM), for autoantibodies to four lesser-known ARSs, finding reactions in two patients.
- The study suggests the need for further investigation into the clinical differences associated with various anti-ARS antibodies, given the distinct symptoms observed in the patients tested.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!